查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球內超音波超音波 (EUS) 市場按產品、類型、應用、最終用戶和地區分類 - 預測至 2029 年
市場調查報告書
商品編碼
1669767

全球內超音波超音波 (EUS) 市場按產品、類型、應用、最終用戶和地區分類 - 預測至 2029 年

Endoscopic Ultrasonography (EUS) Market by Product (Endoscopes, Ultrasound Processors, Ultrasound Needles, Probes), Type (Diagnostic, Therapeutic), Application (Oncology, GI), End User (Hospitals, Ambulatory Surgical Center) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 307 Pages | 訂單完成後即時交付

價格

超音波超音波市場規模預計將從 2024 年的 13.7 億美元成長到 2029 年的 19.3 億美元，預測期內的複合年成長率為 7.1%。

由於癌症發病率上升、低度開發地區醫療基礎設施建設舉措增多、對微創手術的偏好增加以及內視鏡技術的進步等多種因素，超音波超音波市場正在經歷強勁成長。

研究範圍
調查年份 2024-2029
基準年 2023
預測期 2024-2029
考慮單位 金額（美元）
部分 按產品、按類型、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、中東和非洲（海灣合作理事會國家）

在預測期內，內視鏡檢查部分將佔據超音波超音波市場的最大佔有率。對微創手術的需求不斷增加以及提高精確度和控制力的技術進步是關鍵促進因素。此外，隨著胃腸道疾病的發病率上升，需要更有效率、準確的診斷和治療程序，進一步推動了內視鏡檢查的普及。這些因素正在增加內視鏡市場的成長潛力。

根據類型，診斷部分預計將主導超音波超音波市場。這是因為對慢性疾病的早期和準確檢測的需求不斷增加，加上成像技術的進步，提供了即時可視化和高解析度影像。此外，微創、恢復時間短、術後併發症少等優勢使得 EUS 引導下細針抽吸在全球範圍內擴大採用，從而進一步推動了該領域的成長。

根據應用，胃腸病學部門佔據超音波超音波市場第二大市場佔有率。這一比例的上升是由於胃癌、慢性胰臟炎、胰臟癌等胃腸道疾病的發生率不斷上升。此外，老年人口的不斷成長，使他們更容易患上胃腸道疾病，這也推動了對先進診斷程序的需求。這些因素在推動市場成長方面發揮關鍵作用。

按最終用戶分類，預計在預測期內，內超音波超音波市場的醫院部分將佔據最大佔有率，這得益於諸如先進基礎設施（包括各種先進的診斷和治療技術）以及胃腸病學家和內視鏡醫師等熟練的專家等因素。此外，作為重要醫療中心的醫院不斷投資創新的超音波設備，以滿足不斷變化的醫療保健需求，從而推動市場成長。

本報告研究了全球內超音波超音波（EUS）市場，並對全球市場的市場佔有率、收入和收入佔有率進行了詳細分析。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 產業趨勢
  • 價值鏈分析
  • 供應鏈分析
  • 技術分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管分析
  • 定價分析
  • 生態系分析
  • 專利分析
  • 貿易分析
  • 2025-2026 年重要會議與活動
  • 未滿足的需求/最終用戶期望
  • 人工智慧/生成式人工智慧對內視鏡超音波市場的影響
  • 案例研究分析
  • 影響客戶業務的趨勢/干擾
  • 鄰近市場
  • 投資金籌措場景

第6章超音波內視鏡市場（依產品）

  • 介紹
  • 內視鏡檢查
  • 超音波處理器
  • 超音波探頭
  • 超音波針
  • 配件

7. 內視鏡超音波市場（按類型）

  • 介紹
  • 診斷
  • 治療

第 8 章 內視鏡超音波市場（依應用）

  • 介紹
  • 瘤
  • 胃腸道疾病
  • 其他

第 9 章超音波超音波市場（依最終用戶）

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

第 10 章內視鏡超音波市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第11章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2019 至 2023 年收益分析
  • 2023 年市場佔有率分析
  • 公司估值矩陣：主要參與企業，2023 年
  • 公司估值矩陣：Start-Ups/中小企業，2023 年
  • 估值及財務指標
  • 品牌/產品比較
  • 主要參與者研發評估
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • OLYMPUS CORPORATION
    • MEDTRONIC
    • FUJIFILM HOLDINGS CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • PENTAX MEDICAL
    • STERIS
    • CONMED CORPORATION
    • LEPU MEDICAL TECHNOLOGY（BEIJING）CO., LTD.
    • CANON MEDICAL SYSTEMS CORPORATION
    • COOK
  • 其他公司
    • HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
    • SONOSCAPE MEDICAL CORP.
    • ENDOSOUND, INC.
    • LIMACA-MEDICAL
    • BEIJING ZKSK TECHNOLOGY CO., LTD.
    • KAIGEN PHARMA CO., LTD.
    • PIOLAX MEDICAL DEVICES, INC.
    • MICRO-TECH ENDOSCOPY
    • SHAILI ENDOSCOPY
    • ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
    • ENDO-FLEX GMBH
    • ACE MEDICAL DEVICES PVT. LTD.
    • MEDI-GLOBE GMBH
    • MEDORAH MEDITEK PVT. LTD.
    • INNERMEDICAL CO., LTD.

第13章 附錄

Product Code: MD 9316

The endoscopic ultrasonography market is projected to reach USD 1.93 billion by 2029 from USD 1.37 billion in 2024, at a CAGR of 7.1% during the forecast period. The endoscopic ultrasonography market has had strong growth due to a number of factors such as the rising incidences of cancer, growing initiatives to develop healthcare infrastructure in underdeveloped regions, increasing preference for minimally invasive surgeries, and advancements in endoscopic procedures.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsProduct, Type, Application, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, Middle East & Africa (GCC countries)

"By product type, endoscopes segment is expected to account for the largest share in the endoscopic ultrasonography market."

The endoscopes segment accounted for the largest share of the endoscopic ultrasonography market in the forecast period. The increasing demand for minimally invasive procedures, coupled with advancements in technology enhancing precision and control, are significant drivers. Moreover, the rising prevalence of gastrointestinal disorders necessitates more efficient and accurate diagnostic and therapeutic procedures, further boosting the adoption of endoscopes. These factors collectively contribute to the growth potential for this segment within the market.

"Diagnostics segment, by type is expected to have the largest market share in the endoscopic ultrasonography market"

Based on type, the diagnostics segment is expected to dominate the endoscopic ultrasonography market due to the increasing demand for early and accurate detection of chronic diseases coupled with advancements in imaging technology, providing real-time visualization and high-resolution images. Moreover, rising adoption of EUS-guided fine needle aspiration procedures worldwide, driven by their minimally invasive nature and associated benefits like shorter recovery times and reduced post-operative complications have further boosted the growth in this segment, thereby indicating promising growth potential within the endoscopic ultrasonography market.

"The gastrointestinal disorders segment accounted the second-largest market share in the endoscopic ultrasonography market."

By application, the gastrointestinal disorders segment accounted for the second-largest market share in the endoscopic ultrasonography market. This significant share can be attributed to the rising prevalence of gastrointestinal disorders such as gastric cancer, chronic pancreatitis, and pancreatic cancer. Moreover, the growing geriatric population which is more prone to gastrointestinal diseases increasingly demand for advanced diagnostic procedures. These factors' all together play a significant role in propelling market growth.

"Hospitals segment of the endoscopic ultrasonography market is expected to have largest share."

Based on end user, the hospitals segment of the endoscopic ultrasonography market is expected to hold the largest share during the forecast period owing to the factors like the availability of advanced infrastructure constituting broad range of advanced diagnostic and therapeutic techniques, coupled with skilled professionals like gastroenterologists and endoscopists. Moreover, hospitals serving as vital healthcare centers, continuously invest in innovative endoscopic ultrasonography devices to address evolving healthcare demands, thus propelling market growth.

"Asia Pacific to hold third largest market share in the endoscopic ultrasonography market during the forecast period."

The Asia Pacific region accounted the third largest share in the endoscopic ultrasonography market in the forecast period. The growth is attributed to several factors, including the growing advanced healthcare infrastructure, widespread acceptance of innovative medical devices, and increasing healthcare expenditure in Asia Pacific region. Additionally, the ongoing enhancements in endoscopic technologies are anticipated to increase the demand for endoscopic ultrasonography devices in APAC region.

A breakdown of the primary participants (supply side) for the endoscopic ultrasonography market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-20%, and Tier 3-45%
  • By Designation: C-level-35%, Director Level- 45%, and Others-20%
  • By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America-5%, and Middle East & Africa-5%

Prominent players in the endoscopic ultrasonography market include Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), Steris (Ireland), CONMED Corporation (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cook (US), Huaco Healthcare Technologies Co. Ltd.(China), SonoScape Medical Corp.(China), Endosound, Inc.(US), Limaca-Medical (Israel), Beijing ZKSK Technology Co., Ltd. (China), Kaigen Pharma Co., Ltd.(Japan), PIOLAX MEDICAL DEVICES, INC.(Japan), Micro-Tech Endoscopy (US), Shaili Endoscopy (India), Zhejiang Soudon Medical Technology Co., Ltd.(China), ENDO-FLEX GmbH. (Germany), Ace Medical Devices Pvt. Ltd. (India), Medi-Globe GmbH.(Arizona), Medorah Meditek Pvt. Ltd.(India), and InnerMedical Co., Ltd. (China).

Research Coverage:

The report analyzes the endoscopic ultrasonography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall endoscopic ultrasonography market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing requirement for endoscopy procedures to diagnose and treat target diseases, rising incidence of gastrointestinal disorders and colorectal cancer, increased investments, funds, and grants by government bodies and other organizations, technological advancements in endoscopic ultrasonography devices), restraints (high costs of endoscopic ultrasonography procedures, and complications and limitations of endoscopic ultrasonography), opportunities (high market growth potential in emerging economies, and increasing preference for minimally invasive surgeries) and challenges (increasing number of product recalls).
  • Market Penetration: It includes extensive information on products offered by the major players in the global the endoscopic ultrasonography market. The report includes various segments in product, type, application, end user and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global endoscopic ultrasonography market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the endoscopic ultrasonography market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global endoscopic ultrasonography market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key primary insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 DEMAND-SIDE APPROACH
    • 2.2.4 VOLUME DATA ANALYSIS
    • 2.2.5 PROCEDURE DATA ANALYSIS
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER AND COUNTRY, 2023
  • 4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX
  • 4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases
      • 5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer
      • 5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations
      • 5.2.1.4 Technological advancements in endoscopic ultrasound devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs of endoscopic ultrasound procedures
      • 5.2.2.2 Complications and limitations of endoscopic ultrasound
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High market growth potential in emerging economies
      • 5.2.3.2 Increasing preference for minimally invasive surgeries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing number of product recalls
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ULTRASOUND CAPSULE ENDOSCOPY
    • 5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 Contrast-enhanced endoscopic ultrasound
      • 5.6.1.2 Lumen-apposing metal stents
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 Elastography
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.8.2 KEY BUYING CRITERIA
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY FRAMEWORK
      • 5.9.1.1 North America
        • 5.9.1.1.1 US
        • 5.9.1.1.2 Canada
      • 5.9.1.2 Europe
        • 5.9.1.2.1 Germany
        • 5.9.1.2.2 France
        • 5.9.1.2.3 UK
        • 5.9.1.2.4 Italy
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PRICING ANALYSIS
    • 5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021-2023
    • 5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021-2023
  • 5.11 ECOSYSTEM ANALYSIS
    • 5.11.1 ROLE IN ECOSYSTEM
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND
    • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT DATA FOR HS CODE 901890
    • 5.13.2 EXPORT DATA FOR HS CODE 901890
  • 5.14 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.15 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET
  • 5.17 CASE STUDY ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.19 ADJACENT MARKETS
  • 5.20 INVESTMENT & FUNDING SCENARIO

6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 ENDOSCOPES
    • 6.2.1 RADIAL ENDOSCOPES
      • 6.2.1.1 High image quality, improved penetration depth, and excellent maneuverability to propel segment growth
    • 6.2.2 LINEAR ENDOSCOPES
      • 6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth
  • 6.3 ULTRASOUND PROCESSORS
    • 6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING
  • 6.4 ULTRASOUND PROBES
    • 6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH
  • 6.5 ULTRASOUND NEEDLES
    • 6.5.1 FINE NEEDLE ASPIRATION
      • 6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth
    • 6.5.2 FINE NEEDLE BIOPSIES
      • 6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth
    • 6.5.3 OTHER ULTRASOUND NEEDLES
  • 6.6 ACCESSORIES
    • 6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET

7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 DIAGNOSTICS
    • 7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH
  • 7.3 THERAPEUTICS
    • 7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH

8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 ONCOLOGY
    • 8.2.1 UPPER GASTROINTESTINAL ONCOLOGY
      • 8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment
    • 8.2.2 LOWER GASTROINTESTINAL ONCOLOGY
      • 8.2.2.1 High prevalence of colorectal cancer to support segment growth
  • 8.3 GASTROINTESTINAL DISORDERS
    • 8.3.1 PANCREATIC DISORDERS
      • 8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth
    • 8.3.2 OTHER GASTROINTESTINAL DISORDERS
  • 8.4 OTHER APPLICATIONS

9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH
  • 9.3 AMBULATORY SURGERY CENTERS
    • 9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH
  • 9.4 OTHER END USERS

10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period
    • 10.2.3 CANADA
      • 10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth
    • 10.3.3 UK
      • 10.3.3.1 High government healthcare funding to support market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth
    • 10.3.6 SPAIN
      • 10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth
    • 10.4.3 CHINA
      • 10.4.3.1 Large patient pool and high obesity rates to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth
    • 10.4.6 AUSTRALIA
      • 10.4.6.1 Increased patient volume and favorable government initiatives to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth
    • 10.5.3 MEXICO
      • 10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth
    • 10.6.3 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET
  • 11.3 REVENUE ANALYSIS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Type footprint
      • 11.5.5.5 Application footprint
      • 11.5.5.6 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key startups/SMEs
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D ASSESSMENT OF KEY PLAYERS
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES & APPROVALS
    • 11.10.2 EXPANSIONS
    • 11.10.3 DEALS
    • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 OLYMPUS CORPORATION
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches & approvals
        • 12.1.1.3.2 Deals
        • 12.1.1.3.3 Expansions
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 MEDTRONIC
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product approvals
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 FUJIFILM HOLDINGS CORPORATION
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches & approvals
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Other developments
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 BOSTON SCIENTIFIC CORPORATION
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product approvals
        • 12.1.4.3.2 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 PENTAX MEDICAL
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches & approvals
        • 12.1.5.3.2 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 STERIS
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
        • 12.1.6.3.2 Expansions
    • 12.1.7 CONMED CORPORATION
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product approvals
    • 12.1.9 CANON MEDICAL SYSTEMS CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
    • 12.1.10 COOK
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches
        • 12.1.10.3.2 Deals
        • 12.1.10.3.3 Expansions
  • 12.2 OTHER PLAYERS
    • 12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
    • 12.2.2 SONOSCAPE MEDICAL CORP.
    • 12.2.3 ENDOSOUND, INC.
    • 12.2.4 LIMACA-MEDICAL
    • 12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD.
    • 12.2.6 KAIGEN PHARMA CO., LTD.
    • 12.2.7 PIOLAX MEDICAL DEVICES, INC.
    • 12.2.8 MICRO-TECH ENDOSCOPY
    • 12.2.9 SHAILI ENDOSCOPY
    • 12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
    • 12.2.11 ENDO-FLEX GMBH
    • 12.2.12 ACE MEDICAL DEVICES PVT. LTD.
    • 12.2.13 MEDI-GLOBE GMBH
    • 12.2.14 MEDORAH MEDITEK PVT. LTD.
    • 12.2.15 INNERMEDICAL CO., LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ENDOSCOPIC ULTRASOUND MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD)
  • TABLE 3 ENDOSCOPIC ULTRASOUND MARKET: STUDY ASSUMPTIONS
  • TABLE 4 ENDOSCOPIC ULTRASOUND MARKET: RISK ASSESSMENT
  • TABLE 5 US: ESTIMATED NUMBER OF NEW COLORECTAL CANCER CASES, BY AGE AND SEX (2023)
  • TABLE 6 MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 7 GENERIC DIAGNOSTIC ENDOSCOPIC ULTRASOUND PROCEDURE COST IN ALBERTA, CANADA (2023)
  • TABLE 8 COST OF RECTAL ENDOSCOPIC ULTRASOUND FOR US (2023)
  • TABLE 9 COMPANY EXPANSIONS IN EMERGING ECONOMIES
  • TABLE 10 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2020-2022
  • TABLE 11 ENDOSCOPIC ULTRASOUND MARKET: PORTER'S FIVE FORCES
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 14 REGULATORY STANDARDS/APPROVALS REQUIRED FOR ENDOSCOPY, BY COUNTRY
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021-2023
  • TABLE 19 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021-2023
  • TABLE 20 ENDOSCOPIC ULTRASOUND MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 ENDOSCOPIC ULTRASOUND MARKET: LIST OF PATENTS/PATENT APPLICATIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 22 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 23 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 24 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 25 ENDOSCOPIC ULTRASOUND MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 DEVELOPMENT OF ADVANCED SYSTEMS BY OLYMPUS CORPORATION TO ENHANCE MANAGEMENT OF GASTROINTESTINAL AND PANCREATICOBILIARY DISEASES
  • TABLE 27 USE OF SLIM LINEAR ECHOENDOSCOPE IN EUS PROCEDURES BY PENTAX MEDICAL
  • TABLE 28 USE OF SHARKCORE FNB NEEDLE BY MEDTRONIC TO FACILITATE DIAGNOSTIC YIELD IN EUS-GUIDED BIOPSIES
  • TABLE 29 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 30 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 32 RADIAL ENDOSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 LINEAR ENDOSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 35 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 ENDOSCOPIC ULTRASOUND PROBES MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 37 ENDOSCOPIC ULTRASOUND PROBES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 FINE NEEDLE ASPIRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 FINE NEEDLE BIOPSIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 OTHER ULTRASOUND NEEDLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 ENDOSCOPIC ULTRASOUND MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE 2022-2029 (USD MILLION)
  • TABLE 45 ENDOSCOPIC ULTRASOUND MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ENDOSCOPIC ULTRASOUND MARKET FOR THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION 2022-2029 (USD MILLION)
  • TABLE 48 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 UPPER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 LOWER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 53 NUMBER OF PROCEDURES FOR GASTROINTESTINAL DISORDERS, BY REGION, 2023 (THOUSAND/MILLION)
  • TABLE 54 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 PANCREATIC DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 OTHER GASTROINTESTINAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 59 ENDOSCOPIC ULTRASOUND MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 ENDOSCOPIC ULTRASOUND MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 ENDOSCOPIC ULTRASOUND MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 72 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
  • TABLE 73 US: KEY MACROINDICATORS
  • TABLE 74 US: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 75 US: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 US: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 US: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 US: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 79 US: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 US: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 US: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 82 CANADA: KEY MACROINDICATORS
  • TABLE 83 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 84 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 CANADA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 88 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 97 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 100 GERMANY: KEY MACROINDICATORS
  • TABLE 101 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 102 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 GERMANY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 106 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 109 UK: KEY MACROINDICATORS
  • TABLE 110 UK: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 111 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 UK: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 UK: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 UK: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 115 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 UK: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 UK: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 118 FRANCE: KEY MACROINDICATORS
  • TABLE 119 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 FRANCE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 124 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 127 ITALY: KEY MACROINDICATORS
  • TABLE 128 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 129 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 ITALY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 133 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 136 SPAIN: KEY MACROINDICATORS
  • TABLE 137 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 138 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 SPAIN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 142 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 145 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 146 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 REST OF EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 162 JAPAN: KEY MACROINDICATORS
  • TABLE 163 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 164 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 JAPAN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 168 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 171 CHINA: KEY MACROINDICATORS
  • TABLE 172 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 173 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 CHINA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 177 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 180 INDIA: KEY MACROINDICATORS
  • TABLE 181 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 182 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 INDIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 186 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 189 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 190 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 191 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 SOUTH KOREA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 195 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 199 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 200 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 AUSTRALIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 204 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 208 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 215 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 224 BRAZIL: KEY MACROINDICATORS
  • TABLE 225 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 226 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 BRAZIL: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 230 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 233 MEXICO: KEY MACROINDICATORS
  • TABLE 234 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 235 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 MEXICO: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 237 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 239 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 242 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 243 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 247 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 256 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 272 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 275 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET
  • TABLE 276 ENDOSCOPIC ULTRASOUND MARKET: DEGREE OF COMPETITION
  • TABLE 277 ENDOSCOPIC ULTRASOUND MARKET: REGION FOOTPRINT
  • TABLE 278 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT FOOTPRINT
  • TABLE 279 ENDOSCOPIC ULTRASOUND MARKET: TYPE FOOTPRINT
  • TABLE 280 ENDOSCOPIC ULTRASOUND MARKET: APPLICATION FOOTPRINT
  • TABLE 281 ENDOSCOPIC ULTRASOUND MARKET: END-USER FOOTPRINT
  • TABLE 282 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 283 ENDOSCOPIC ULTRASOUND MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 284 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 285 ENDOSCOPIC ULTRASOUND MARKET: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 286 ENDOSCOPIC ULTRASOUND MARKET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 288 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 289 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 290 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 291 OLYMPUS CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 292 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 293 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 294 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 295 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 296 MEDTRONIC: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 297 MEDTRONIC: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 298 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 299 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 300 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 301 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 302 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
  • TABLE 303 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 304 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 305 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 306 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 307 PENTAX MEDICAL: COMPANY OVERVIEW
  • TABLE 308 PENTAX MEDICAL: PRODUCTS OFFERED
  • TABLE 309 PENTAX MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 310 PENTAX MEDICAL: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 311 STERIS: COMPANY OVERVIEW
  • TABLE 312 STERIS: PRODUCTS OFFERED
  • TABLE 313 STERIS: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 314 STERIS: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 315 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 316 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 317 CONMED CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 318 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 320 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 321 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 322 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 323 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 324 COOK: COMPANY OVERVIEW
  • TABLE 325 COOK: PRODUCTS OFFERED
  • TABLE 326 COOK: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 327 COOK: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 328 COOK: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 329 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
  • TABLE 330 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW
  • TABLE 331 ENDOSOUND, INC.: COMPANY OVERVIEW
  • TABLE 332 LIMACA-MEDICAL: COMPANY OVERVIEW
  • TABLE 333 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 334 KAIGEN PHARMA CO., LTD.: COMPANY OVERVIEW
  • TABLE 335 PIOLAX MEDICAL DEVICES, INC.: COMPANY OVERVIEW
  • TABLE 336 MICRO-TECH ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 337 SHAILI ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 338 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 339 ENDO-FLEX GMBH: COMPANY OVERVIEW
  • TABLE 340 ACE MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 341 MEDI-GLOBE GMBH: COMPANY OVERVIEW
  • TABLE 342 MEDORAH MEDITEK PVT. LTD.: COMPANY OVERVIEW
  • TABLE 343 INNERMEDICAL CO., LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ENDOSCOPIC ULTRASOUND MARKET: MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • FIGURE 2 ENDOSCOPIC ULTRASOUND MARKET: YEARS CONSIDERED
  • FIGURE 3 ENDOSCOPIC ULTRASOUND MARKET: RESEARCH DESIGN
  • FIGURE 4 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 ENDOSCOPIC ULTRASOUND MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 ENDOSCOPIC ULTRASOUND MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND OTHER PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 11 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION (2023)
  • FIGURE 13 ENDOSCOPIC ULTRASOUND MARKET: TOP-DOWN APPROACH
  • FIGURE 14 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY-SIDE ANALYSIS (2023)
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 ENDOSCOPIC ULTRASOUND MARKET: CAGR PROJECTIONS
  • FIGURE 17 ENDOSCOPIC ULTRASOUND MARKET: DATA TRIANGULATION
  • FIGURE 18 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPIC ULTRASOUND MARKET
  • FIGURE 23 RISING PREVALENCE OF CANCER AND INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET
  • FIGURE 24 CHINA AND HOSPITALS SEGMENTS COMMANDED LARGEST SHARE IN ASIA PACIFIC ENDOSCOPIC ULTRASOUND MARKET IN 2023
  • FIGURE 25 JAPAN TO WITNESS HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 26 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 28 ENDOSCOPIC ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 SHARE OF SURGEONS PERFORMING OVER 100 ENDOSCOPIC PROCEDURES PER YEAR GLOBALLY, BY REGION (2024)
  • FIGURE 30 NUMBER OF ANNUAL PLANNED SESSIONS PER INDIVIDUAL IN UK (2021)
  • FIGURE 31 ENDOSCOPIC ULTRASOUND MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 ENDOSCOPIC ULTRASOUND MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 36 AVERAGE SELLING PRICE OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY TYPE (2023)
  • FIGURE 37 ENDOSCOPIC ULTRASOUND MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 ENDOSCOPIC ULTRASOUND MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 39 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 41 ENDOSCOPIC ULTRASOUND MARKET: IMPACT OF AI/GEN AI
  • FIGURE 42 ENDOSCOPIC ULTRASOUND MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 43 ENDOSCOPIC ULTRASOUND MARKET: ADJACENT MARKETS
  • FIGURE 44 ENDOSCOPIC ULTRASOUND MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO (2019-2024)
  • FIGURE 45 ENDOSCOPIC ULTRASOUND MARKET REGIONAL SNAPSHOT
  • FIGURE 46 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT
  • FIGURE 49 MARKET SHARE ANALYSIS OF PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET (2023)
  • FIGURE 50 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 51 ENDOSCOPIC ULTRASOUND MARKET: COMPANY FOOTPRINT
  • FIGURE 52 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 EV/EBITDA OF KEY VENDORS
  • FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 ENDOSCOPIC ULTRASOUND MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 56 ENDOSCOPIC ULTRASOUND MARKET: R&D ASSESSMENT OF KEY PLAYERS (2021-2023)
  • FIGURE 57 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 59 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 61 STERIS: COMPANY SNAPSHOT
  • FIGURE 62 CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 63 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 64 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT